DPIIT recognised startup Government of India
Startup India
Inpure Pharmaceuticals Private Limited
Inpure Pharmaceuticals Private Limited - food and beverages in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹2.27 Lakh
▲ 2170% YoY
Net loss · FY 2023
₹1.19 Lakh
Net margin -52.5%
EBITDA · FY 2023
₹2,004
EBITDA margin 0.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2023
Balance sheet date
About Inpure Pharmaceuticals Private Limited
Data last updated:
Inpure Pharmaceuticals Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 10 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PTC360118.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hardik Madaan and Taruna Sabikhi.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No 63 63A Kh No 141/20 Dichaon Enclave Najafgarh, Delhi, India – 110043.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.27 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.19 Lakh (net margin -52.5%) and EBITDA of ₹2,004 (EBITDA margin 0.9%).
Inpure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0012618).
Company details
CIN U24304DL2020PTC360118
Registration Number 360118
Incorporation Date 10 January 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0012618
Key People
Hardik Madaan Director Taruna Sabikhi Director Recognitions & Rankings of Inpure Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-DL-10-0012618
Contact details
Inpure Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 63 63A Kh No 141/20 Dichaon Enclave Najafgarh, Delhi, India – 110043
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Inpure Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Inpure Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Inpure Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inpure Pharmaceuticals Private Limited, buy the company report.
Financials of Inpure Pharmaceuticals Private Limited
FY 2023 filings availableInpure Pharmaceuticals Private Limited reported revenue of ₹2.27 Lakh (up 2170% YoY) for FY 2023.
Revenue · FY 2023
₹2.27 Lakh ▲ 2170%
Net loss · FY 2023
₹1.19 Lakh margin -52.5%
EBITDA · FY 2023
₹2,004 margin 0.9%
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2,004 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.19 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.9% | |||
| Net Profit Margin | -52.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Inpure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Inpure Pharmaceuticals Private Limited
Inpure Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hardik Madaan | Director | 10 Jan 2020 | 6 Years 10 Months | Current |
| Taruna Sabikhi | Director | 10 Jan 2020 | 6 Years 10 Months | Current |
Peer comparison
Inpure Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Levisto Pharmaceuticals Private Limited | ₹2.29 Lakh (FY 2023) | Panchkula, Haryana, India | ||||
| Oricon Pharmaceuticals Private Limited | ₹2.28 Lakh (FY 2024) | -61.0% | Rohtak, Haryana, India | |||
| Inpure Pharmaceuticals Private Limitedthis company | ₹2.27 Lakh (FY 2023) | -₹1.19 Lakh | -52.5% | 2170.0% | Delhi, India | |
| Skymed Pharmaceuticals Private Limited | ₹2.27 Lakh (FY 2024) | -16.0% | New Delhi, Delhi, India | |||
| Advance Poly Pathic Pharmaceuticals Limited | ₹2.24 Lakh (FY 2024) | -65.0% | Patna, Bihar, India |
To see the full peer comparison of Inpure Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inpure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inpure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Inpure Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Inpure Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Hardik Madaan was appointed as Director on 10 Jan 2020.
AGM
Inpure Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Inpure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi I.
Appointed
Hardik Madaan was appointed as Director.
Appointed
Taruna Sabikhi was appointed as Director.
Incorporation
10 Jan 2020
Inpure Pharmaceuticals Private Limited was registered on 10 Jan 2020 with Roc Delhi I & aged 6 years 10 months as per MCA records.
Frequently asked questions
Inpure Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 10 January 2020 (6+ years old) and is registered under CIN U24304DL2020PTC360118.
Inpure Pharmaceuticals has 2 current directors:
- Hardik Madaan - Director
- Taruna Sabikhi - Director
The latest financial statements of Inpure Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Inpure Pharmaceuticals is U24304DL2020PTC360118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inpure Pharmaceuticals was incorporated on 10 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Inpure Pharmaceuticals by revenue are Levisto Pharmaceuticals Private Limited, Oricon Pharmaceuticals Private Limited, Skymed Pharmaceuticals Private Limited, Advance Poly Pathic Pharmaceuticals Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Hardik Madaan was appointed as Director on 10 Jan 2020. Taruna Sabikhi was appointed as Director on 10 Jan 2020.
Yes, Inpure Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Inpure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0012618).
The registered office of Inpure Pharmaceuticals is at Plot No 63 63A Kh No 14120 Dichaon Enclave Najafgarh, Delhi, India – 110043.
Inpure Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages